Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-018332
Filing Date
2013-03-28
Accepted
2013-03-28 16:41:15
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT v334741_10k.htm 10-K 912870
2 EXHIBIT 21.1 v334741_ex21-1.htm EX-21.1 2643
3 EXHIBIT 31.1 v334741_ex31-1.htm EX-31.1 9276
4 EXHIBIT 31.2 v334741_ex31-2.htm EX-31.2 9459
5 EXHIBIT 32.1 v334741_ex32-1.htm EX-32.1 4863
  Complete submission text file 0001144204-13-018332.txt   6363034

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvlt-20121231.xml EX-101.INS 700934
7 XBRL TAXONOMY EXTENSION SCHEMA nvlt-20121231.xsd EX-101.SCH 81289
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvlt-20121231_cal.xml EX-101.CAL 57691
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvlt-20121231_def.xml EX-101.DEF 337268
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvlt-20121231_lab.xml EX-101.LAB 592236
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvlt-20121231_pre.xml EX-101.PRE 415296
Mailing Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458
Business Address ONE GATEWAY CENTER, SUITE 504 NEWTON MA 02458 617-244-1616
NOVELOS THERAPEUTICS, INC. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-119366 | Film No.: 13724531
SIC: 2834 Pharmaceutical Preparations